Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

14.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Inflammatory Response01:28

Inflammatory Response

19.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
19.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

804
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
804
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

19.5K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
19.5K
Inflammation01:38

Inflammation

65.5K
Overview
65.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational study.

Modern rheumatology·2025
Same author

A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.

Cancer science·2021
Same author

Outlook of IL-6 signaling blockade for COVID-19 pneumonia.

Inflammation and regeneration·2020
Same author

The immunobiology of humanized Anti-IL6 receptor antibody: From basic research to breakthrough medicine.

Journal of translational autoimmunity·2020
Same author

Translating IL-6 biology into effective treatments.

Nature reviews. Rheumatology·2020
Same author

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.

Frontiers in immunology·2018

Related Experiment Video

Updated: Apr 16, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

8.1K

IL-6 as a target in inflammation.

Misato Hashizume1, Yoshiyuki Ohsugi

  • 1Product Research Department, Chugai Pharmaceutical Co. Ltd., 1-135, Komakado, Gotemba, Shizuoka, 412-8513, Japan. hashizumemst@chugai-pharm.co.jp.

Endocrine, Metabolic & Immune Disorders Drug Targets
|March 17, 2015
PubMed
Summary

Interleukin-6 (IL-6) is crucial for immune responses but its overproduction drives chronic inflammatory diseases. Understanding IL-6 signaling pathways is key for developing new therapies.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Interleukin-6 (IL-6) possesses a distinct signaling pathway.
  • Soluble IL-6 receptors in peripheral blood allow IL-6 to act on diverse cell types.
  • IL-6 regulates critical biological processes including immune responses, hematopoiesis, and acute-phase reactions.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying IL-6 functions.
  • To explore the role of IL-6 signaling in disease pathogenesis.
  • To investigate the therapeutic potential of IL-6 signaling inhibitors.

Main Methods:

  • Analysis of IL-6 signaling pathways.
  • Investigation of IL-6's role in various biological events.
  • Examination of IL-6 overproduction in disease models.

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

8.1K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K

Main Results:

  • IL-6's involvement in immune responses, hematopoiesis, and acute-phase reactions confirmed.
  • Overproduction of IL-6 linked to the pathogenesis of chronic inflammatory diseases.
  • The unique signaling pathway of IL-6 identified.

Conclusions:

  • IL-6 plays a dual role in biological processes, essential for normal function but detrimental when overproduced.
  • Further research into IL-6 molecular mechanisms and signaling inhibition is vital for understanding disease and developing novel therapeutics.